Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Alpha Teknova, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q2 2023
- Shares held
- 5.21M
- +726.0K (+16.2%) vs. Q2 2023
- Total value
- $14.5M
- +$2.51M (+20.9%) vs. Q2 2023
- New holders
- 2
- 8 more added
- Sold out
- 5
- 13 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TKNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $51.7M |
| Q1 2026 | 78 | $22.1M |
| Q4 2025 | 70 | $26.6M |
| Q3 2025 | 67 | $45.9M |
| Q2 2025 | 68 | $37.6M |
| Q1 2025 | 65 | $32.0M |
| Q4 2024 | 47 | $53.2M |
| Q3 2024 | 32 | $24.9M |
| Q2 2024 | 28 | $8.03M |
| Q1 2024 | 31 | $15.6M |
| Q4 2023 | 31 | $21.0M |
| Q3 2023 | 28 | $14.5M |
| Q2 2023 | 31 | $12.0M |
| Q1 2023 | 44 | $16.3M |
| Q4 2022 | 47 | $30.2M |
| Q3 2022 | 54 | $21.3M |
| Q2 2022 | 52 | $58.1M |
| Q1 2022 | 51 | $95.3M |
| Q4 2021 | 52 | $146.3M |
| Q3 2021 | 52 | $178.0M |
| Q2 2021 | 50 | $153.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Alpha Teknova, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 1,764,570 | $4.92M | 0.01% | +433,829+32.6% | Added |
| Balyasny Asset Management LLC | 1,066,472 | $2.98M | 0.01% | +18,957+1.8% | Added |
| Platinum Investment Management Ltd | 834,529 | $2.33M | 0.09% | +525,351+169.9% | Added |
| Vanguard Group Inc | 402,380 | $1.12M | 0.00% | −1,353−0.3% | Reduced |
| Redmile Group, LLC | 284,564 | $793.9K | 0.04% | −24,288−7.9% | Reduced |
| Conestoga Capital Advisors, LLC | 237,729 | $663.3K | 0.01% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 233,746 | $652.2K | 0.12% | +57,432+32.6% | Added |
| Geode Capital Management, LLC | 73,896 | $206.2K | 0.00% | +5,281+7.7% | Added |
| Bridgeway Capital Management, LLC | 70,000 | $195.3K | 0.00% | 00.0% | Unchanged |
| Premier Fund Managers Ltd | 58,830 | $159.0K | 0.01% | −143,227−70.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 46,100 | $128.6K | 0.00% | +800+1.8% | Added |
| BlackRock Inc. | 41,380 | $115.5K | 0.00% | −560−1.3% | Reduced |
| Dimensional Fund Advisors LP | 27,543 | $76.8K | 0.00% | −12,197−30.7% | Reduced |
| State Street Corp | 21,945 | $61.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,533 | $46.1K | 0.00% | −5,089−23.5% | Reduced |
| Brown Advisory Inc | 11,133 | $31.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,990 | $11.1K | 0.00% | −499−11.1% | Reduced |
| UBS Group AG | 3,332 | $9.30K | 0.00% | −1,159−25.8% | Reduced |
| Morgan Stanley | 1,665 | $4.64K | 0.00% | −558−25.1% | Reduced |
| JPMorgan Chase & Co | 1,271 | $3.55K | 0.00% | +421+49.5% | Added |
| Qube Research & Technologies Ltd | 1,140 | $3.18K | 0.00% | −8,997−88.8% | Reduced |
| Authentikos Wealth Advisory, LLC | 357 | $996 | 0.00% | +357 | New |
| FMR LLC | 149 | $416 | 0.00% | −1,253−89.4% | Reduced |
| Wells Fargo & Company | 96 | $268 | 0.00% | +1+1.1% | Added |
| Citigroup Inc | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1 | $3 | 0.00% | −2−66.7% | Reduced |
| Royal Bank of Canada | 27 | $0 | 0.00% | −121−81.8% | Reduced |
| Gotham Asset Management, LLC | 4,808 | – | – | +4,808 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −59,700−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −44,757−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −15,484−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −1,898−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −57−100.0% | Sold out |